EUVIMEDEUVIMED entdecken
Crossref

Gold Nanoparticle-Integrated Glucose Oxidase Encapsulated in Zeolitic Imidazolate Framework (ZIF-8) as a Glucose-Responsive Drug Delivery System for Type 2 Diabetes Mellitus

Farhan Fikri Safii, Khoirunnisa Dwi Az Zahra Firdausi, Firdhea Rahma Cahyani, Yoga Tribakti Rachmad, Ratna Ediati

Journal of Metastable and Nanocrystalline Materials · 2025

DOI: 10.4028/p-0eoqvo ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Metastable and Nanocrystalline Materials, 2025. Verfasst von Farhan Fikri Safii und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) is a chronic metabolic disease with an increasing prevalence. Conventional treatments, such as insulin injections, often result in unstable blood glucose levels. This study explores a glucose-responsive drug delivery system based on Zeolitic Imidazolate Framework-8 (ZIF-8) integrated with Glucose Oxidase (GOx) and gold nanoparticles (AuNP) for Type 2 Diabetes Mellitus (DM-2) treatment. The combination of pH-sensitive ZIF-8 with glucose-responsive GOx aims to regulate glucose fluctuations via controlled drug release. Characterization results show that synthesized ZIF-8 maintains its structure and morphology, even after the integration of metformin, GOx, and AuNP, confirmed by X-Ray Diffraction (XRD), Fourier Transform Infra-Red (FT-IR), and Field Emission Scanning Electron Microscopy (FE-SEM) analyses. In vivo testing demonstrated that Met-GOx@ZIF8/AuNP effectively stabilizes blood glucose levels in diabetic mice, indicating its high potential as a glucose-responsive DM-2 therapy. In vivo experiments showed that metformin encapsulated in ZIF-8 with GOx and AuNP significantly improved glycemic control compared to conventional treatment. This system offers a promising solution for patients with busy lifestyles by providing a controlled, glucose-responsive drug release.

Zitieren

APA

Safii, F. F., Firdausi, K. D. A. Z., Cahyani, F. R., Rachmad, Y. T., & Ediati, R. (2025). Gold Nanoparticle-Integrated Glucose Oxidase Encapsulated in Zeolitic Imidazolate Framework (ZIF-8) as a Glucose-Responsive Drug Delivery System for Type 2 Diabetes Mellitus. Journal of Metastable and Nanocrystalline Materials. https://doi.org/10.4028/p-0eoqvo

Vancouver

Safii FF, Firdausi KDAZ, Cahyani FR, Rachmad YT, Ediati R. Gold Nanoparticle-Integrated Glucose Oxidase Encapsulated in Zeolitic Imidazolate Framework (ZIF-8) as a Glucose-Responsive Drug Delivery System for Type 2 Diabetes Mellitus. Journal of Metastable and Nanocrystalline Materials. 2025. doi:10.4028/p-0eoqvo

BibTeX
@article{Safii2025,
  author = {Safii, Farhan Fikri and Firdausi, Khoirunnisa Dwi Az Zahra and Cahyani, Firdhea Rahma and Rachmad, Yoga Tribakti and Ediati, Ratna},
  title = {Gold Nanoparticle-Integrated Glucose Oxidase Encapsulated in Zeolitic Imidazolate Framework (ZIF-8) as a Glucose-Responsive Drug Delivery System for Type 2 Diabetes Mellitus},
  journal = {Journal of Metastable and Nanocrystalline Materials},
  year = {2025},
  doi = {10.4028/p-0eoqvo}
}
Kostenlos starten →